| CD | Cluster of Differentiation |
| CR | Complete Response |
| ctDNA | circulating tumor DNA |
| CTLA-4 | Cytotoxic T-Lymphocyte-Associated protein 4 |
| DFS | Disease-Free Survival |
| EFS | Event-Free Survival |
| ERAS | Enhanced Recovery After Surgery |
| ICI | Immune Checkpoint Inhibitor |
| LAG-3 | Lymphocyte-Activation Gene 3 |
| MPR | Major Pathological Response |
| NSCLC | Non-Small Cell Lung Cancer |
| ORR | Objective Response Rate |
| OS | Overall Survival |
| pCR | Pathological Complete Response |
| PD | Progressive Disease |
| PD-1 | Programmed cell Death protein 1 |
| PD-L1 | Programmed Death Ligand 1 |
| PFS | Progression-Free Survival |
| PR | Partial Response |
| RATS | Robotic-Assisted Thoracic Surgery |
| SCLC | Small Cell Lung Cancer |
| SD | Stable Disease |
| TILs | Tumor Infiltrating Lymphocytes |
| TMB | Tumor Mutational Burden |
| VATS | Video-Assisted Thoracic Surgery |